Oral ibandronate for the treatment of metastatic bone disease in breast cancer: Efficacy and safety results from a randomized, double-blind, placebo-controlled trial (multiple letters) [1]

A. M. Westermann, Debu Tripathy

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Oral ibandronate for the treatment of metastatic bone disease in breast cancer: Efficacy and safety results from a randomized, double-blind, placebo-controlled trial (multiple letters) [1]'. Together they form a unique fingerprint.